ARCHIVED: NOT AVAILABLE FOR CREDIT
Risk Mitigation in Breast Predictive Factor Testing
In this course, the risks to laboratories and pathologists inherent in biomarker testing are described along with a process to identify and mitigate the risks of testing.
Originally presented on February 10, 2015, in Salt Lake City, Utah.
Lecture Presenter
Elizabeth H. Hammond, MD, FCAP Consulting Pathologist |
Dr. Elizabeth Hammond is a consulting pathologist with Intermountain Healthcare and professor of pathology and adjunct professor of internal medicine (cardiology) at the University of Utah School of Medicine. She is also a past member of Intermountain’s Board of Trustees. She was recently recognized and presented with two awards presented by the College of American Pathologists (CAP): 1) the CAP Pathology Advancement Award, of which she is the first recipient; and 2) the CAP Excellence in Education Award.
Objectives
After this presentation, participants will be able to:
- Describe the categories of risks of biomarker testing for laboratories and give examples.
- Define a process of identifying specific laboratory risks of biomarker testing and then defining interventions that will mitigate those risks for the laboratories.
Sponsored by:
University of Utah School of Medicine, Department of Pathology, and ARUP Laboratories